Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zenas BioPharma (ZBIO) Shares Issued (2023 - 2025)

Zenas BioPharma (ZBIO) has 3 years of Shares Issued data on record, last reported at -$1.5 million in Q3 2025.

  • For Q3 2025, Shares Issued fell 100.66% year-over-year to -$1.5 million; the TTM value through Sep 2025 reached $353000.0, down 99.85%, while the annual FY2024 figure was $275000.0, 137.07% up from the prior year.
  • Shares Issued reached -$1.5 million in Q3 2025 per ZBIO's latest filing, down from $1.7 million in the prior quarter.
  • Across five years, Shares Issued topped out at $234.3 million in Q3 2024 and bottomed at -$1.5 million in Q3 2025.
  • Average Shares Issued over 3 years is $29.4 million, with a median of $88000.0 recorded in 2024.
  • The widest YoY moves for Shares Issued: up 1288.71% in 2025, down 100.66% in 2025.
  • A 3-year view of Shares Issued shows it stood at $50000.0 in 2023, then skyrocketed by 54.0% to $77000.0 in 2024, then tumbled by 2106.49% to -$1.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Issued were -$1.5 million in Q3 2025, $1.7 million in Q2 2025, and $99000.0 in Q1 2025.